Agilus Diagnostics

{{Short description|Indian diagnostics chain}}

{{Use dmy dates|date=May 2025}}

{{Use Indian English|date=May 2025}}

{{Infobox company

| name = Agilus Diagnostics

| logo = Agilus Diagnostics Logo.png

| trade_name =

| former_name = SRL Limited{{cite news |last1=Unnikrishnan |first1=C. H. |title=SRL Ranbaxy mulls merger with Fortis Health |url=https://www.livemint.com/Companies/p1zXW9BWaZbWHyBffrKc1N/SRL-Ranbaxy-mulls-merger-with-Fortis-Health.html |access-date=9 January 2023 |work=Mint |date=22 August 2008 |language=en}}

| type = Public

| foundation = {{start date and age|7 July 1995}}

| hq_location_city = Gurgaon, Haryana, India

| locations = 418+

| area_served = India, Dubai, Afghanistan and Nepal

| key_people = Anand Kuppuswamy (MD & CEO){{cite news |last1=V |first1=Narayanan |title=SRL Diagnostics to set up central reference lab in Chennai |url=https://www.thehindubusinessline.com/news/srl-diagnostics-to-set-up-central-reference-lab-in-chennai/article65510713.ece |access-date=9 January 2023 |work=The Hindu Businessline |date=9 June 2022 |language=en}}

| services = Pathology, Radiology

| industry = Diagnostics

| num_employees =

| revenue = {{increase}} {{INRconvert|1605|c}} (FY22)

| operating_income = {{increase}} {{INRconvert|425|c}} (FY22){{cite news |title=SRL Limited |url=https://crisil.com/mnt/winshare/Ratings/RatingList/RatingDocs/SRLLimited_August%2004,%202022_RR_298808.html |access-date=6 January 2023 |work=CRISIL}}

| owners = {{ubl|Fortis Healthcare (57.68%)|NYLIM (15.86%)|Resurgence PE (8.05%)|IFC (7.61%){{cite news |title=Agilus Diagnostics withdraws IPO plans, says SEBI |url=https://www.moneycontrol.com/news/business/ipo/agilus-diagnostics-withdraws-ipo-plans-says-sebi-12333021.html |access-date=23 February 2024 |work=Moneycontrol |date=22 February 2024 |language=en}}}}

| subsid = {{ubl|Agilus Pathlabs Reach Limited|DDRC Agilus Pathlabs Limited}}

| website = {{URL|https://agilusdiagnostics.com/}}

}}

Agilus Diagnostics Limited (formerly known as SRL Limited) is an Indian multinational diagnostics company providing diagnostic services in pathology and radiology. Agilus Diagnostics has its headquarters and corporate office in Gurgaon.

History

The company was founded in 1995 by brothers Shivinder Mohan Singh and Malvinder Mohan Singh as Specialty Ranbaxy Limited (SRL), a 50:50 joint venture between Ranbaxy Laboratories and US-based Specialty Laboratories.{{cite news |title=Ranbaxy, Specialty Lab Unit To Be Opened Today |url=https://www.business-standard.com/article/specials/ranbaxy-specialty-lab-unit-to-be-opened-today-197031501080_1.html |access-date=29 November 2024 |work=Business Standard}}{{cite news |last1=Kandhari |first1=Ruhi |title=Can IHH help SRL finally scratch its 10-year itch? |url=https://the-ken.com/story/ihh-srl-scratch-10-year-itch/ |access-date=9 January 2023 |work=The Ken |date=7 May 2019}} It became the first pathology company in India to receive accreditation from National Accreditation Board.{{cite news |last1=D'Silva |first1=Jeetha |title=SRL Ranbaxy plans to set up four more labs |url=https://economictimes.indiatimes.com/srl-ranbaxy-plans-to-set-up-four-more-labs/articleshow/39801162.cms |access-date=9 January 2023 |work=The Economic Times}}

In 2001, SRL became a wholly-owned subsidiary of Ranbaxy Laboratories after Ranbaxy bought out Specialty Laboratories' stake; the company was subsequently renamed SRL Ranbaxy.{{cite news |title=Specialty, Ranbaxy to call it a day |url=https://timesofindia.indiatimes.com/business/india-business/specialty-ranbaxy-to-call-it-a-day/articleshow/507328169.cms |access-date=29 November 2024 |work=The Times of India |date=25 July 2001}}

In 2008, SRL Ranbaxy was renamed as Super Religare Laboratories.{{cite news |title=SRL Ranbaxy rechristened as Super Religare Lab |url=https://www.livemint.com/Companies/lRChPDXFOaUyRgQz7eXgSI/SRL-Ranbaxy-rechristened-as-Super-Religare-Lab.html |access-date=9 January 2023 |work=mint |date=29 September 2008 |language=en}}

In 2010, Super Religare Laboratories acquired Piramal Diagnostic Services and its network of 107 laboratories from Piramal Healthcare for {{INR}}600 crore.{{cite news |title=Piramal Healthcare completes sale of diagnostics arm to SRL |url=https://www.business-standard.com/article/companies/piramal-healthcare-completes-sale-of-diagnostics-arm-to-srl-110082100115_1.html |access-date=9 January 2023 |work=Business Standard India |date=21 August 2010}}

In 2011, Fortis Healthcare completed the acquisition of 74.59% stake in Super Religare Laboratories.{{cite news |title=Fortis completes acquisition of 74.59% stake in SRL |url=https://www.business-standard.com/article/companies/fortis-completes-acquisition-of-74-59-stake-in-srl-111051200262_1.html |access-date=9 January 2023 |work=Business Standard India |date=12 May 2011}} After being acquired by Fortis, the company rebranded itself as SRL Diagnostics.{{cite news |last1=Vijayraghavan |first1=Kala |title=Super Religare Laboratories rechristens itself as 'SRL Diagnostics'; launches new logo |url=https://economictimes.indiatimes.com/news/company/corporate-trends/super-religare-laboratories-rechristens-itself-as-srl-diagnostics-launches-new-logo/articleshow/15402356.cms |access-date=9 January 2023 |work=The Economic Times}}

In 2021, SRL Diagnostics acquired the remaining stake in its Kerala-based joint venture, DDRC, for {{INR}}350 crore. With the addition of DDRC's 220 labs to its lab network, SRL became the biggest pathology lab chain in India with a total of 430 labs.{{cite news |last1=Jayan |first1=T. V. |title=SRL becomes India’s largest pathlab chain after acquiring DDRC |url=https://www.thehindubusinessline.com/companies/srl-becomes-indias-largest-pathlab-chain-after-acquiring-ddrc/article34199522.ece |access-date=9 January 2023 |work=The Hindu Businessline |date=30 March 2021 |language=en}}

In 2023, SRL Diagnostics changed its name to Agilus Diagnostics.{{Cite news |last=Pilla |first=Viswanath |date=2023-05-27 |title=SRL Diagnostics rebrands as Agilus Diagnostics |work=The Economic Times |url=https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/srl-diagnostics-rebrands-as-agilus-diagnostics/articleshow/100555193.cms |access-date=2023-12-09 |issn=0013-0389}}

Operations

{{third-party|section|date=November 2018}}

Agilus has two reference labs one in Goregaon (Mumbai), and one in Gurgaon (Haryana), India. The company has more than 418 networking laboratories,{{Cite web|url=https://agilusdiagnostics.com/about-us/about-srl|title = Agilus Diagnostics}} including four "Centers of Excellence", 26 radiology/imaging centers, 40 NABL accredited, and four CAP-accredited labs and a footprint spanning over 9000 collection points in India.{{Cite web|url=https://www.ibef.org/industry/healthcare-india/showcase/srl-diagnostics|title=According to Ibef.org}} Along with this, the company also has large labs in Dubai, Sri Lanka and Nepal, and about 70 different collection points in various countries outside India.{{Cite news|url=https://news.microsoft.com/en-in/microsoft-partners-with-srl-diagnostics-to-expand-ai-network-for-healthcare-to-pathology/|title=Microsoft News}}

Agilus Diagnostics claims to offer more than 3,500 different tests in pathology, radiology, wellness, occupational health and clinical trials and also carries out more than 107,000 tests in a day.{{Cite web|url=https://www.ibef.org/industry/healthcare-india/showcase/srl-diagnostics|title=According to IBEF}} Agilus Diagnostics operates diagnostic centres, collection centres, and laboratories. Agilus Diagnostics also offers tests in pathology covering biochemistry, immunology, herpetology, clinical pathology, histopathology and immunohistochemistry, microbiology, molecular biology, cytogenetics, and flow cytometry.{{Cite web|url=https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=30968069|title=Bloomberg|website=Bloomberg News}}

References